FI117373B - Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti - Google Patents

Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti Download PDF

Info

Publication number
FI117373B
FI117373B FI962156A FI962156A FI117373B FI 117373 B FI117373 B FI 117373B FI 962156 A FI962156 A FI 962156A FI 962156 A FI962156 A FI 962156A FI 117373 B FI117373 B FI 117373B
Authority
FI
Finland
Prior art keywords
tablet
domperidone
paracetamol
tablets
tablet according
Prior art date
Application number
FI962156A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962156A (fi
FI962156A0 (fi
Inventor
Gordon Prudhoe
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI117373(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI962156A0 publication Critical patent/FI962156A0/fi
Publication of FI962156A publication Critical patent/FI962156A/fi
Application granted granted Critical
Publication of FI117373B publication Critical patent/FI117373B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
FI962156A 1994-02-28 1996-05-22 Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti FI117373B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94200498 1994-02-28
EP94200498 1994-02-28
EP9500719 1995-02-27
PCT/EP1995/000719 WO1995022974A2 (en) 1994-02-28 1995-02-27 Film coated tablet of paracetamol and domperidone

Publications (3)

Publication Number Publication Date
FI962156A0 FI962156A0 (fi) 1996-05-22
FI962156A FI962156A (fi) 1996-06-04
FI117373B true FI117373B (fi) 2006-09-29

Family

ID=8216670

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962156A FI117373B (fi) 1994-02-28 1996-05-22 Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti

Country Status (30)

Country Link
US (1) US5814339A (ja)
EP (1) EP0749308B1 (ja)
JP (1) JP2931409B2 (ja)
KR (1) KR100202154B1 (ja)
CN (1) CN1084616C (ja)
AT (1) ATE240102T1 (ja)
AU (1) AU703242B2 (ja)
BR (1) BR9506903A (ja)
CA (1) CA2182004C (ja)
CY (1) CY2383B1 (ja)
CZ (1) CZ291999B6 (ja)
DE (1) DE69530759T2 (ja)
DK (1) DK0749308T3 (ja)
ES (1) ES2199982T3 (ja)
FI (1) FI117373B (ja)
HK (1) HK1010687A1 (ja)
HU (1) HU228149B1 (ja)
IL (1) IL112802A (ja)
MX (1) MX9603690A (ja)
MY (1) MY115433A (ja)
NO (1) NO309455B1 (ja)
NZ (1) NZ281236A (ja)
PL (1) PL179080B1 (ja)
PT (1) PT749308E (ja)
RU (1) RU2153337C2 (ja)
SI (1) SI0749308T1 (ja)
SK (1) SK282506B6 (ja)
TW (1) TW466119B (ja)
WO (1) WO1995022974A2 (ja)
ZA (1) ZA951616B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
US20100255096A1 (en) * 2007-04-26 2010-10-07 Aronchick Craig A Compositions And Methods For Transmucosal Delivery Of Domperidone
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
BRPI0819231B8 (pt) * 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
US8343533B2 (en) * 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
FR2992218B1 (fr) * 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
JP6505721B2 (ja) 2014-01-10 2019-04-24 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド 高周波及び損失性被覆粒子を使用した錠剤の製造プロセス
JP7296185B2 (ja) * 2016-02-04 2023-06-22 シンリックス ファーマ、エルエルシー 重水素化ドンペリドン組成物及び疾患の治療方法
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
CN110302169A (zh) * 2019-08-01 2019-10-08 张慧芬 一种滑膜衣片剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
JPH08502032A (ja) * 1992-07-07 1996-03-05 セプラコア インコーポレーテッド 胃食道逆流疾患およびその他の障害を治療するために▲（−）▼シサプリドを使用する方法
TW272942B (ja) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
NO962153L (no) 1996-08-26
CZ291999B6 (cs) 2003-07-16
WO1995022974A3 (en) 1995-09-21
SK282506B6 (sk) 2002-10-08
DK0749308T3 (da) 2003-09-01
IL112802A (en) 1999-08-17
MX9603690A (es) 1997-06-28
HK1010687A1 (en) 1999-06-25
RU2153337C2 (ru) 2000-07-27
DE69530759D1 (de) 2003-06-18
AU1812395A (en) 1995-09-11
IL112802A0 (en) 1995-05-26
ZA951616B (en) 1996-08-27
CY2383B1 (en) 2004-06-04
HU228149B1 (en) 2012-12-28
US5814339A (en) 1998-09-29
NO962153D0 (no) 1996-05-28
PT749308E (pt) 2003-10-31
WO1995022974A2 (en) 1995-08-31
CZ225596A3 (en) 1996-11-13
NO309455B1 (no) 2001-02-05
FI962156A (fi) 1996-06-04
CN1141589A (zh) 1997-01-29
NZ281236A (en) 2001-11-30
PL314850A1 (en) 1996-09-30
SK103296A3 (en) 1997-03-05
HU9601384D0 (en) 1996-07-29
EP0749308A1 (en) 1996-12-27
TW466119B (en) 2001-12-01
CA2182004A1 (en) 1995-08-31
AU703242B2 (en) 1999-03-25
KR100202154B1 (ko) 1999-06-15
PL179080B1 (pl) 2000-07-31
CN1084616C (zh) 2002-05-15
ATE240102T1 (de) 2003-05-15
MY115433A (en) 2003-06-30
JP2931409B2 (ja) 1999-08-09
EP0749308B1 (en) 2003-05-14
ES2199982T3 (es) 2004-03-01
JPH09500910A (ja) 1997-01-28
CA2182004C (en) 2000-10-31
HUT74477A (en) 1996-12-30
DE69530759T2 (de) 2004-03-18
FI962156A0 (fi) 1996-05-22
BR9506903A (pt) 1997-09-09
SI0749308T1 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
KR101445757B1 (ko) 옥시코돈을 포함하는 과립 및 경구 붕해 정제
PL199779B1 (pl) Tabletka o dużej zawartości monosulfonianu 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-(4-pirydyn-3-ylo)pirymidyn-2-yloamino)fenylo]-benzamidu i sposób jej wytwarzania
KR20050083816A (ko) 24시간 효능의 서방 트라마돌 조성물
AU2009349125B2 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
AU762829B2 (en) New oral formulation for 5-HT4 agonists or antagonists
WO2011102506A1 (ja) 経口用徐放性固形製剤
JP2008536922A (ja) オランザピンの医薬用経口崩壊錠
JP2002509882A (ja) フルオキセチンおよびそのエナンチオマーの安定した投薬剤形
CA2938909A1 (en) Orally disintegrating tablet of nabilone comprising mannitol-based granules
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
WO2005051350A2 (en) Water dispersible tablet
MXPA05004412A (es) Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas.
JP3836893B2 (ja) ポリカルボフィルカルシウム含有製剤
MXPA05002136A (es) Forma de dosificacion de liberacion controlada de nitrofurantoina.
UA79567C2 (en) Orodispersible pharmaceutical composition of antithrombolic compound
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
HU225779B1 (en) Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
KR20010052895A (ko) 치료 방법
JP2005194225A (ja) 胃内崩壊性錠剤
MXPA01001854A (en) New oral formulation for 5-ht4

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117373

Country of ref document: FI

MA Patent expired